Comparing the current results to its competitors, Amphastar Pharmaceuticals Inc reported Revenue increase in the 1 quarter 2026 by 0.38 % year on year. The revenue growth was below Amphastar Pharmaceuticals Inc 's competitors' average revenue growth of 3.53 %, achieved in the same quarter.
With modest revenue growth of 0.38 % within Overall company, Amphastar Pharmaceuticals Inc failed to increase sales with the same pace, like most of company's peers within this division. << More on AMPH Market Share.
*Market share is calculated based on total revenue.
Publicly Traded Peers of Amphastar Pharmaceuticals Inc
Viatris Inc Share Performance
+35.47%
This Year
Viatris Inc
Profile
Viatris Inc operates as a global pharmaceutical company, specializing in the development, manufacturing, and distribution of a wide range of generic and branded medicines, as well as biosimilars.
Perrigo Company Plc is a leading global healthcare supplier that focuses on providing affordable, high-quality over-the-counter (OTC) healthcare and wellness products. The company operates through its own worldwide distribution network, manufacturing a wide range of products and medications. By leveraging its extensive portfolio and efficient supply chain, Perrigo aims to enhance the well-being of consumers by making quality healthcare products more accessible.
Pfizer Inc operates as a global pharmaceutical company that focuses on researching, developing, manufacturing, and marketing innovative medicines. Its business model emphasizes significant investment in research and development to build a diverse portfolio of therapies across various therapeutic areas, while leveraging strategic alliances and collaborations to enhance commercialization and drive growth.
Mallinckrodt Plc's business model revolves around acquiring and developing branded pharmaceutical products, as well as manufacturing and distributing generic and specialty pharmaceuticals. They aim to address unmet medical needs and improve patient lives through their diverse portfolio of drugs.
Sources:
Amphastar Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Amphastar Pharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
